Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?

Clyman RI, Couto J, Murphy GM.

Semin Perinatol. 2012 Apr;36(2):123-9. doi: 10.1053/j.semperi.2011.09.022. Review.

2.
3.

Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management.

Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K.

Arch Dis Child Fetal Neonatal Ed. 2005 May;90(3):F235-9.

4.

Therapeutic closure of the ductus arteriosus: benefits and limitations.

Mercanti I, Boubred F, Simeoni U.

J Matern Fetal Neonatal Med. 2009;22 Suppl 3:14-20. doi: 10.1080/14767050903198132. Review.

PMID:
19925358
5.

Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosus.

Wickremasinghe AC, Rogers EE, Piecuch RE, Johnson BC, Golden S, Moon-Grady AJ, Clyman RI.

J Pediatr. 2012 Dec;161(6):1065-72. doi: 10.1016/j.jpeds.2012.05.062. Epub 2012 Jul 13.

6.

Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.

Herrera C, Holberton J, Davis P.

Cochrane Database Syst Rev. 2004;(1):CD003480. Review. Update in: Cochrane Database Syst Rev. 2007;(2):CD003480.

PMID:
14974018
7.

Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.

Herrera C, Holberton J, Davis P.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD003480. Review.

PMID:
17443527
8.

Late closure of the ductus arteriosus using indomethacin in the preterm infant.

Kresch MJ, Moya FR, Ascuitto RJ, Ross-Ascuitto NT, Heusser F.

Clin Pediatr (Phila). 1988 Mar;27(3):140-3.

PMID:
3342597
9.

Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.

Malviya M, Ohlsson A, Shah S.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003951. doi: 10.1002/14651858.CD003951.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD003951.

PMID:
18254035
10.
11.

Feeding practices and patent ductus arteriosus ligation preferences-are they related?

Jhaveri N, Soll RF, Clyman RI.

Am J Perinatol. 2010 Sep;27(8):667-74. doi: 10.1055/s-0030-1249764. Epub 2010 Mar 11.

PMID:
20225172
12.

Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants.

Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I.

Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F45-52. doi: 10.1136/adc.2009.168682. Epub 2010 Sep 27. Review.

PMID:
20876595
13.

Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.

Hammerman C, Glaser J, Kaplan M, Schimmel MS, Ferber B, Eidelman AI.

Pediatrics. 1998 Nov;102(5):E56.

PMID:
9794986
14.

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

Ohlsson A, Walia R, Shah S.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003481. doi: 10.1002/14651858.CD003481.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD003481.

PMID:
18254020
15.

[Is it possible to predict the success of pharmacological closure of persistent ductus arteriosus in prematurely born neonates?].

Fendler W, Bernas S, Jarosik K, Piotrowski A.

Anestezjol Intens Ter. 2008 Jul-Sep;40(3):156-61. Polish.

PMID:
19469116
16.

Patent ductus arteriosus in infants <29 weeks gestation--outcomes and factors affecting closure.

Popat H, Kapoor V, Travadi J.

Indian Pediatr. 2012 Aug;49(8):615-20. Epub 2012 Jan 17.

18.

Does patent ductus arteriosus affect feed tolerance in preterm neonates?

Patole SK, Kumaran V, Travadi JN, Brooks JM, Doherty DA.

Arch Dis Child Fetal Neonatal Ed. 2007 Jan;92(1):F53-5. Epub 2006 Jun 23.

19.
20.

Comparison of two neonatal indomethacin protocols: efficacy and outcome for patent ductus arteriosus closure.

Rosito G, Sum K, Chorne N.

J Clin Pharm Ther. 2010 Oct;35(5):589-92. doi: 10.1111/j.1365-2710.2009.01142.x.

PMID:
20831682

Supplemental Content

Support Center